Skip to Main Content

Author Details

Helen J Ross
Mayo Clinic
1982
86
33
PMIDPaper TitleJournal TitlePublished Year
35194958Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer.Thorac Cancer2022
35392854Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.BMC Cancer2022
35362092Field cancerization in breast cancer.J Pathol2022
35927150The molecular landscape of pancreatic ductal adenocarcinoma.Pancreatology2022
33477882The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.Cancers (Basel)2021
33739449Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.Int J Cancer2021
33451936Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application.Pancreatology2021
32885042Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer.NPJ Breast Cancer2020
31764021Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.Am J Clin Oncol2020
33083649Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.Adv Radiat Oncol2020
32887725Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.Clin Cancer Res2020
28981577'Multi-omic' data analysis using O-miner.Brief Bioinform2019
32529140Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.Adv Radiat Oncol2019
31155475Small-cell Lung Cancer in Very Elderly (â¿¥ 80 Years) Patients.Clin Lung Cancer2019
30755501A Case of Donor-Transmitted Non-Small Cell Lung Cancer After Liver Transplantation: An Unwelcome Guest.Oncologist2019
30476477Expert Consensus Document on Pulmonary Metastasectomy.Ann Thorac Surg2019
28753852DESNT: A Poor Prognosis Category of Human Prostate Cancer.Eur Urol Focus2018
30023104Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality.J Thorac Dis2018
29674442First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma.Oncologist2018
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
28292578Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].EBioMedicine2017
28286059Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.EBioMedicine2017
28089762Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).J Thorac Oncol2017
29258618A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer.J Immunother Cancer2017
28859365Incidence of brain metastasis from esophageal cancer.Dis Esophagus2017
25824527Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.Dis Esophagus2016
26572708The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.Eur Urol2016
27732966HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.Oncotarget2016
27694157A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.Oncologist2016
27247118Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neck.Crit Rev Oncol Hematol2016
26859444The genetic classification of prostate cancer: what's on the horizon?Future Oncol2016
26881390A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.Oncotarget2016
27061083Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.Radiat Oncol2016
26950096Gene regulatory mechanisms underpinning prostate cancer susceptibility.Nat Genet2016
25371077PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.J Thorac Oncol2015
26501111Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.EBioMedicine2015
26108458A new scoring system for predicting survival in patients with non-small cell lung cancer.Cancer Med2015
25548099Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer.Mol Cancer Res2015
25560400HES5 silencing is an early and recurrent change in prostate tumourigenesis.Endocr Relat Cancer2015
24266955Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.Ann Thorac Surg2014
25456371Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.Lancet Oncol2014
24997137Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.Lung Cancer2014
25047675Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.Lung Cancer2014
25157767NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status.J Thorac Oncol2014
24737870HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.EMBO Mol Med2014
23232491A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528.J Thorac Oncol2013
22333598A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer.Br J Cancer2012
22730461Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.Proc Natl Acad Sci U S A2012
22782333Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis.Ann Oncol2012
22306652Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.Nat Genet2012
  • 1 - 50 of 86

Recommended Authors

Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 2
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 2
The University of Manchester
Career Start Year 2000
Number of shared co-authors 8
Olivia Newton-John Cancer Wellness and Research Centre
Career Start Year 2000
Number of shared co-authors 3
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 7
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 4
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 7
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 8
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 12
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 3
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
Injury Prevention Research Center, University of North Carolina
Career Start Year 1994
Number of shared co-authors 5
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 4
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 2
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 12
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 6
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 8
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 5
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 26
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1967
Number of shared co-authors 11

Collaborators

University of Oxford, John Radcliffe Hospital
Co-authored papers 14
University of Oxford
Co-authored papers 12
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 10
Queen's University Belfast
Co-authored papers 9
The Medical School, The University of Sheffield
Co-authored papers 8
University College London
Co-authored papers 7
University of Cambridge
Co-authored papers 6
Norwich Medical School, University of East Anglia
Co-authored papers 6
University of St Andrews
Co-authored papers 6
University of Oxford
Co-authored papers 6
The Institute of Cancer Research
Co-authored papers 5
University College London
Co-authored papers 5
Karolinska Institute
Co-authored papers 4
Karolinska Institute
Co-authored papers 4
Karolinska Institute
Co-authored papers 4
Mayo Clinic
Co-authored papers 3
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 3
Norwich Medical School, University of East Anglia
Co-authored papers 3
University of Pennsylvania
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
University College London
Co-authored papers 2
University of Toronto
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 2
The Institute of Cancer Research
Co-authored papers 2